Amgen, Inc.
7 FDA drug recalls on record.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2025-02-27 | Class II | Neupogen | Ongoing |
| 2025-02-27 | Class II | Neupogen | Ongoing |
| 2022-05-02 | Class II | MVASI (bevacizumab-awwb), Injection, For Intravenous Infusion After Dilution, 100 mg/4 ml, | Terminated |
| 2017-09-13 | Class II | Procrit | Terminated |
| 2017-08-04 | Class II | Procrit | Terminated |
| 2016-12-15 | Class II | Kyprolis | Terminated |
| 2013-09-17 | Class II | Prolia | Terminated |